THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •1h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•2h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•4h ago
← Back to News Feed
The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •1h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•2h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•4h ago
← Back to News Feed